Anri Nishinaka
Gifu-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Topical Application of RNAi Therapy Using Surface-Modified Liposomes for Treating Retinal-Vein Occlusion.
Journal: Molecules (Basel, Switzerland)
Published: May 02, 2025
Sphingosine-1-phosphate receptor 1/5 selective agonist alleviates ocular vascular pathologies.
Journal: Scientific reports
Published: October 12, 2023
BCL6B Contributes to Ocular Vascular Diseases via Notch Signal Silencing.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 20, 2023
Arctigenin Prevents Retinal Edema in a Murine Retinal Vein Occlusion Model.
Journal: Biological & pharmaceutical bulletin
Published: March 01, 2023
A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component.
Journal: Frontiers in immunology
Published: December 05, 2022
Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.
Journal: Molecular vision
Published: August 03, 2022
Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.
Journal: Investigative ophthalmology & visual science
Published: July 13, 2022
TRPV4 channels promote vascular permeability in retinal vascular disease.
Journal: Experimental eye research
Published: June 11, 2022
Role of Activating Transcription Factor 4 in Murine Choroidal Neovascularization Model.
Journal: International journal of molecular sciences
Published: July 29, 2021
Establishment of a pigmented murine model abundant with characteristics of retinal vein occlusion.
Journal: Experimental eye research
Published: October 20, 2020
Oral administration of NSP-116, a free radical scavenger, suppresses the symptoms of retinal vein occlusion in the murine model.
Journal: Experimental eye research
Published: September 15, 2020
Last Updated: 09/26/2026